Orally administrable opioid formulations having extended duration of effect

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7270831
APP PUB NO 20030180361A1
SERIAL NO

10392586

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Sustained release oral solid dosage forms of opioid analgesics are provided as multiparticulate systems which are bioavailable and which provide effective blood levels of the opioid analgesic for at least about 24 hours. A unit dose of the opioid analgesic contains a plurality of substrates including the opioid analgesic in sustained release form. The substrates have a diameter from about 0.1 mm to about 3 mm.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • PURDUE PHARMA L.P.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chasin, Mark Manalapan, NJ 116 12746
Oshlack, Benjamin New York, NY 246 21121

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation